THE WHAT? L’Oréal has reported a record-breaking year in 2021, with sales growth up 16 percent on a like-for-like basis to €32.2 billion.
THE DETAILS The historic year was driven by an ‘infinite appetite for beauty’ according to Chief Executive Nicolas Hieronimus in an interview with the Financial Times.
Net profit after controlling interest hit €4.59 billion, up 29 percent YOY. Looking at sectors, Latin America saw the biggest growth, up 20.6 per cent, followed by North Asia, North America, Europe and South Asia Pacific, Middle East and North America (SAPMENA) at 18.6, 18.1, 10.7 and 10 percent respectively.
L’Oréal also reported a successful Q4, with global sales of €9.09 billion, up 15.4 YOY. Active Cosmetics saw the biggest growth, up 28.4 percent, while Professional Products was up 18.5 percent, followed by L’Oréal Luxe and Consumer products at 16.5 and 10 percent respectively.
L’Oréal Luxe became the company’s largest division in 2021, with ‘remarkable success’ in fragrances, with Active Cosmetics doubling in the past four years. The company’s e-commerce channel grew by 25.7 percent, accounting for 28.9 percent.
The cosmetics giant increased its advertising and promotion expenses during 2021 by 190 basis points, at 32.8 percent of sales.
THE WHY? According to Hieronimus, “2021 was a historic year for L’Oréal. Thanks to the expertise, passion and commitment of our 85,400 L’Oréalians around the world, the Group achieved record growth of +16.1%1, twice that of the worldwide beauty market. L’Oréal gained market share in all Zones, Divisions and categories. Over two years, the Group achieved growth of +11.3% like-for-like, spectacularly outperforming a market that had returned almost to 2019 levels.”
Aesthetic injectable companies refer to businesses or companies that specialize in manufacturing, distributing, or providing aesthetic injectable products and services. These companies focus on developing and supplying injectable substances used for cosmetic purposes, typically administered by qualified medical professionals. Aesthetic injectable companies play a crucial role in the field of aesthetic medicine and cosmetic dermatology by offering a variety of injectable products designed to enhance facial features, reduce wrinkles, and improve overall skin appearance.
Key aspects of aesthetic injectable companies include:
-
Product Development: These companies research, develop, and manufacture aesthetic injectables such as dermal fillers, botulinum toxins (e.g., Botox), collagen stimulators, and other specialized formulations. They often innovate new products to meet evolving market demands and technological advancements.
-
Distribution and Sales: Aesthetic injectable companies distribute their products through authorized channels, including healthcare providers, medical spas, and aesthetic clinics. They may also sell directly to licensed professionals who administer these treatments.
-
Regulatory Compliance: Due to the medical nature of their products, aesthetic injectable companies adhere to strict regulatory guidelines and obtain necessary approvals from health authorities (e.g., FDA in the United States) to ensure safety, efficacy, and quality standards.
-
Training and Support: Many companies provide training and educational support to healthcare professionals on the proper use, administration techniques, and safety protocols associated with their injectable products. This ensures that practitioners can deliver treatments effectively and safely.
-
Customer Support: Aesthetic injectable companies offer customer support services to healthcare providers and consumers, addressing inquiries, providing product information, and assisting with product usage and troubleshooting.
